The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists ...
Business analysts from the University of Melbourne, in Australia, the Nanyang Technological University, in Singapore, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback